Rigrodsky & Long, P.A.:
-
Do you, or did you, own shares of Globus Medical, Inc. (NYSE: GMED)?
-
Did you purchase your shares between February 26, 2014 and August
5, 2014, inclusive?
-
Did you lose money in your investment?
Rigrodsky
& Long, P.A. reminds shareholders of Globus Medical, Inc.
(“Globus” or the “Company”) (NYSE: GMED)
of an upcoming deadline involving a securities fraud class action
lawsuit commenced against the Company. A complaint was filed in the
United States District Court for the Eastern District of Pennsylvania on
behalf of all persons or entities that purchased the common stock of
Globus between February 26, 2014 and August 5, 2014, inclusive (the
“Class Period”), alleging violations of the Securities Exchange Act of
1934 against the Company and certain of its officers (the “Complaint”).
If you wish to serve as lead plaintiff, you must move the Court no later
than November 30, 2015. A lead plaintiff is a representative
party acting on behalf of other class members in directing the
litigation. Any member of the proposed class may move the court to serve
as lead plaintiff through counsel of their choice. One of the key
factors in selecting the lead plaintiff is the size of the loss. The
larger the size of your economic loss, the greater the likelihood that
you may be appointed to serve as lead plaintiff. Alternatively, you may
choose to do nothing and remain an absent class member.
If you purchased shares of Globus during the Class Period, or purchased
shares prior to the Class Period and still
hold Globus, and wish to discuss this action or have any questions
concerning this notice or your rights or interests, please contact Timothy
J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2
Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by
e-mail to info@rl-legal.com; or
at: http://rigrodskylong.com/investigations/globus-medical-inc-gmed.
Attorney advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151113005001/en/
Copyright Business Wire 2015